Skip to content

Safety and Efficacy of Laser Therapy in Gynaecology

Safety and Efficacy of Er:YAG and Nd:YAG Laser Therapy in Gynecology: A Retrospective Case Series.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04073082
Enrollment
300
Registered
2019-08-29
Start date
2019-07-24
Completion date
2020-01-24
Last updated
2019-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bartholin Cyst, Cervical Intraepithelial Neoplasia, Episiotomy Scar, Genital Wart, Herpes Genitalis, Hidradenitis Suppurativa, Labial Reduction Surgery, Lichen Sclerosus

Brief summary

The aim of this study is to retrospectively evaluate the effectiveness and safety of Er:YAG laser for treatment of different gynecological indication, e.g. genital lesions, Bartholin's cyst, condyloma, episiotomy scars, lesions of hydradenitis suppurativa and use of laser in genital surgery used in private practice.

Interventions

None listed

Sponsors

Juna d.o.o.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients with any of the selected gynecology indications, treated with laser in the period 2013-2018 * signed informed consent

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Safety - occurence of adverse effects.[1 year]Recording if any adverse effects occur.
Efficacy - number of laser treatments.[1 year]Number of laser treatments needed for lesion clearance.

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026